A detailed history of Hudson Bay Capital Management LP transactions in United Therapeutics Corp stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 35,509 shares of UTHR stock, worth $12.9 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
35,509
Previous 75,000 52.65%
Holding current value
$12.9 Million
Previous $23.9 Million 46.74%
% of portfolio
0.06%
Previous 0.13%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$311.04 - $363.55 $11 Million - $12.9 Million
35,509 New
35,509 $12.7 Million
Q1 2024

May 15, 2024

BUY
$210.76 - $249.51 $1.88 Million - $2.22 Million
8,900 Added 80.18%
20,000 $4.59 Million
Q4 2023

Feb 14, 2024

BUY
$214.88 - $256.94 $2.39 Million - $2.85 Million
11,100 New
11,100 $2.44 Million
Q1 2021

May 14, 2021

SELL
$153.94 - $174.85 $1.54 Million - $1.75 Million
-10,000 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$101.87 - $151.79 $2.55 Million - $3.79 Million
-25,000 Reduced 71.43%
10,000 $1.52 Million
Q3 2020

Nov 12, 2020

BUY
$99.9 - $121.13 $3.5 Million - $4.24 Million
35,000 New
35,000 $3.54 Million
Q2 2020

Aug 12, 2020

SELL
$92.74 - $125.82 $6.49 Million - $8.81 Million
-70,000 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$79.39 - $115.35 $2.38 Million - $3.46 Million
-30,000 Reduced 30.0%
70,000 $6.64 Million
Q4 2019

Feb 12, 2020

BUY
$78.31 - $95.34 $7.83 Million - $9.53 Million
100,000 New
100,000 $8.81 Million
Q3 2019

Nov 13, 2019

SELL
$74.85 - $85.99 $1.12 Million - $1.29 Million
-15,000 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$76.06 - $120.81 $1.14 Million - $1.81 Million
15,000 New
15,000 $1.17 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Hudson Bay Capital Management LP Portfolio

Follow Hudson Bay Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.